<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immune Modeling & Immunotherapy | Cristea Lab</title>
    <link rel="stylesheet" href="../styles.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        .research-hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.9;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2.5rem;
            color: var(--primary-color);
            margin-bottom: 2rem;
            border-bottom: 3px solid var(--primary-color);
            padding-bottom: 0.5rem;
        }
        .project-card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--shadow);
            padding: 2.5rem;
            margin-bottom: 2rem;
            border-left: 5px solid var(--accent-color);
            transition: var(--transition);
        }
        .project-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.15);
        }
        .project-card h3 {
            font-size: 1.8rem;
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .project-card h4 {
            font-size: 1.3rem;
            color: var(--accent-color);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            font-size: 1.1rem;
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .project-details {
            background: var(--bg-light);
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        .project-details h5 {
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .methodology-list {
            list-style: none;
            padding: 0;
        }
        .methodology-list li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #eee;
        }
        .methodology-list li:last-child {
            border-bottom: none;
        }
        .methodology-list li::before {
            content: 'ðŸ”¬';
            margin-right: 0.5rem;
        }
        .impact-highlight {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid var(--secondary-color);
            margin: 2rem 0;
        }
        .impact-highlight h4 {
            color: var(--secondary-color);
            margin-bottom: 1rem;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--primary-color);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.9rem;
            font-weight: 500;
        }
        .immune-highlight {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #4caf50;
            margin: 2rem 0;
        }
        .immune-highlight h4 {
            color: #2e7d32;
            margin-bottom: 1rem;
        }
        .data-integration-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .data-type-card {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            border-top: 4px solid var(--accent-color);
            text-align: center;
        }
        .clinical-application {
            background: linear-gradient(135deg, #fff3e0, #ffe0b2);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #ff9800;
            margin: 2rem 0;
        }
        .clinical-application h4 {
            color: #f57c00;
            margin-bottom: 1rem;
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">Computational Cancer Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../team.html" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>Immune Modeling & Immunotherapy</h1>
                <p>
                    Integrative longitudinal immune modeling combining single cell transcriptomic and T-cell receptor 
                    sequencing clinical patient data to predict immunotherapy responses and understand immune evasion mechanisms.
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    Our immune modeling research integrates cutting-edge single-cell technologies with T-cell receptor sequencing 
                    to understand how pancreatic cancer evades immune surveillance and develops resistance to immunotherapy. 
                    We develop predictive models that can identify patients most likely to respond to immune checkpoint blockade 
                    and other immunotherapeutic approaches.
                </div>
                
                <div class="immune-highlight">
                    <h4>Immunotherapy Revolution</h4>
                    <p>
                        While immunotherapy has transformed treatment for many cancers, pancreatic cancer remains largely 
                        resistant to these approaches. Our research aims to overcome this resistance by understanding the 
                        unique immune landscape of pancreatic tumors and identifying combination strategies that can 
                        make immunotherapy effective in this challenging cancer type.
                    </p>
                </div>

                <div class="data-integration-grid">
                    <div class="data-type-card">
                        <i class="fas fa-dna" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                        <h4>Single-cell RNA-seq</h4>
                        <p>Comprehensive immune cell profiling</p>
                    </div>
                    <div class="data-type-card">
                        <i class="fas fa-shield-virus" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                        <h4>TCR Sequencing</h4>
                        <p>T-cell receptor repertoire analysis</p>
                    </div>
                    <div class="data-type-card">
                        <i class="fas fa-user-md" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                        <h4>Clinical Data</h4>
                        <p>Treatment outcomes and survival</p>
                    </div>
                    <div class="data-type-card">
                        <i class="fas fa-microscope" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                        <h4>Spatial Analysis</h4>
                        <p>Tumor-immune interactions</p>
                    </div>
                </div>
            </div>

            <!-- Project A: Tumor and Blood Analysis -->
            <div class="research-section">
                <h2>Project A: Integrative Analysis of Tumor and Blood</h2>
                <div class="project-card">
                    <h3>Immunotherapy-Treated Pancreatic Cancer Patients</h3>
                    <div class="project-description">
                        We perform comprehensive integrative analysis of tumor tissue and peripheral blood from pancreatic 
                        cancer patients treated with immunotherapy. This dual-compartment approach reveals how systemic 
                        immune responses correlate with local tumor immune environments and treatment outcomes.
                    </div>
                    
                    <div class="project-details">
                        <h5>Multi-compartment Analysis</h5>
                        <ul class="methodology-list">
                            <li>Simultaneous analysis of tumor-infiltrating and circulating immune cells</li>
                            <li>Longitudinal tracking of immune responses during treatment</li>
                            <li>Integration of single-cell transcriptomics with TCR repertoire data</li>
                            <li>Identification of shared vs. compartment-specific immune signatures</li>
                            <li>Correlation with clinical response and survival outcomes</li>
                        </ul>
                    </div>

                    <div class="clinical-application">
                        <h4>Clinical Translation</h4>
                        <p>
                            This research enables the development of liquid biopsy-based biomarkers for immunotherapy 
                            response prediction. By analyzing peripheral blood samples, we can non-invasively monitor 
                            treatment responses and adjust therapeutic strategies in real-time, improving patient outcomes 
                            while reducing the need for invasive tumor biopsies.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Key Research Questions</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li>How do systemic immune responses predict local tumor responses to immunotherapy?</li>
                            <li>Which circulating immune cell populations are most predictive of treatment success?</li>
                            <li>How does T-cell receptor diversity change during immunotherapy treatment?</li>
                            <li>Can peripheral blood signatures replace tumor biopsies for response prediction?</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Immunotherapy</span>
                        <span class="tech-tag">Liquid Biopsy</span>
                        <span class="tech-tag">Multi-compartment Analysis</span>
                        <span class="tech-tag">Longitudinal Profiling</span>
                        <span class="tech-tag">Biomarker Discovery</span>
                    </div>
                </div>
            </div>

            <!-- Project B: Data Repository -->
            <div class="research-section">
                <h2>Project B: Pancreatic Cancer Data Repository</h2>
                <div class="project-card">
                    <h3>Hale Center Clinical Trial Data Integration</h3>
                    <div class="project-description">
                        We are building a comprehensive data repository that integrates multi-modal immune profiling data 
                        from ongoing clinical trials at the Hale Center for Pancreatic Cancer. This resource will serve 
                        as a foundation for AI-driven discovery and enable cross-trial comparisons and meta-analyses.
                    </div>

                    <div class="project-details">
                        <h5>Repository Components</h5>
                        <ul class="methodology-list">
                            <li>Standardized data collection protocols across clinical trials</li>
                            <li>Multi-modal data integration (genomics, proteomics, imaging)</li>
                            <li>Longitudinal patient tracking and outcome correlation</li>
                            <li>AI-ready data formatting and annotation</li>
                            <li>Secure, HIPAA-compliant data storage and access systems</li>
                            <li>Collaborative research platform for multi-institutional studies</li>
                        </ul>
                    </div>

                    <div class="impact-highlight">
                        <h4>Research Acceleration</h4>
                        <p>
                            This repository will dramatically accelerate pancreatic cancer research by providing researchers 
                            with access to high-quality, standardized datasets. The integration of multiple data types and 
                            clinical outcomes will enable machine learning approaches that would be impossible with smaller, 
                            single-trial datasets.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Data Standards & Quality</h5>
                        <p>
                            We implement rigorous quality control measures and standardized protocols to ensure data 
                            consistency across different clinical trials and timepoints. This includes standardized 
                            sample collection, processing protocols, and bioinformatics pipelines that enable meaningful 
                            cross-study comparisons.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Clinical Trials</span>
                        <span class="tech-tag">Data Integration</span>
                        <span class="tech-tag">Standardization</span>
                        <span class="tech-tag">Multi-modal Data</span>
                        <span class="tech-tag">Research Infrastructure</span>
                    </div>
                </div>
            </div>

            <!-- Project C: ImmunoProfiler -->
            <div class="research-section">
                <h2>Project C: Predicting Immunotherapy Outcomes</h2>
                <div class="project-card">
                    <h3>Foundation Models for Immunotherapy Response Prediction</h3>
                    <div class="project-description">
                        We develop and apply foundation models for computational pathology to predict patient outcomes 
                        after treatment with immune checkpoint blockade. Using the ImmunoProfiler dataset from DFCI, 
                        we integrate histopathology images with immune profiling data to create comprehensive predictive models.
                    </div>

                    <div class="project-details">
                        <h5>Computational Pathology Integration</h5>
                        <ul class="methodology-list">
                            <li>Foundation model analysis of H&E stained tumor sections</li>
                            <li>Automated immune cell detection and quantification</li>
                            <li>Integration with molecular immune profiling data</li>
                            <li>Multi-modal predictive modeling for treatment response</li>
                            <li>Validation across multiple cancer types and treatment regimens</li>
                        </ul>
                    </div>

                    <div class="clinical-application">
                        <h4>Clinical Decision Support</h4>
                        <p>
                            Our predictive models will be integrated into clinical workflows to help oncologists make 
                            informed decisions about immunotherapy treatment. By analyzing routine pathology samples 
                            with AI, we can provide rapid, accurate predictions of treatment response, enabling 
                            personalized treatment selection and improved patient outcomes.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Model Development & Validation</h5>
                        <p>
                            We employ rigorous machine learning practices including cross-validation, external validation 
                            cohorts, and prospective validation studies. Our models are designed to be robust across 
                            different institutions and patient populations, ensuring broad clinical applicability.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>ImmunoProfiler Dataset Integration</h5>
                        <p>
                            The ImmunoProfiler dataset from DFCI represents one of the largest collections of immune 
                            checkpoint blockade-treated patients with comprehensive molecular and clinical annotation. 
                            Our analysis of this dataset provides unprecedented insights into the mechanisms of 
                            immunotherapy response and resistance.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Foundation Models</span>
                        <span class="tech-tag">Computational Pathology</span>
                        <span class="tech-tag">Checkpoint Blockade</span>
                        <span class="tech-tag">Predictive Modeling</span>
                        <span class="tech-tag">ImmunoProfiler</span>
                    </div>
                </div>
            </div>

            <!-- Methodological Innovations -->
            <div class="research-section">
                <h2>Methodological Innovations</h2>
                <div class="project-card">
                    <h3>Advanced Computational Approaches</h3>
                    <div class="project-description">
                        Our research develops novel computational methods specifically designed for immune system analysis 
                        in cancer. These methodological innovations enable more accurate and comprehensive understanding 
                        of tumor-immune interactions and treatment responses.
                    </div>

                    <div class="project-details">
                        <h5>Novel Analytical Methods</h5>
                        <ul class="methodology-list">
                            <li>Multi-modal data integration algorithms for immune profiling</li>
                            <li>Longitudinal modeling of immune system dynamics</li>
                            <li>Network analysis of T-cell receptor repertoire evolution</li>
                            <li>Machine learning models for immune signature discovery</li>
                            <li>Causal inference methods for treatment effect estimation</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Technical Challenges & Solutions</h5>
                        <p>
                            Immune system analysis presents unique computational challenges including high-dimensional 
                            data integration, temporal dynamics modeling, and rare cell population detection. Our 
                            methodological innovations address these challenges through specialized algorithms and 
                            statistical approaches designed for immune system complexity.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Algorithm Development</span>
                        <span class="tech-tag">Multi-modal Integration</span>
                        <span class="tech-tag">Longitudinal Analysis</span>
                        <span class="tech-tag">Network Analysis</span>
                        <span class="tech-tag">Causal Inference</span>
                    </div>
                </div>
            </div>

            <!-- Key Publications & Software -->
            <div class="research-section">
                <h2>Publications & Software</h2>
                <div class="project-card">
                    <h3>Key Outputs</h3>
                    <div class="project-details">
                        <h5>Recent Publications</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Integrative immune profiling in pancreatic cancer</strong> - Manuscript in preparation, submission planned for Nature Immunology 2025</li>
                            <li><strong>Foundation models for immunotherapy prediction</strong> - Analysis of ImmunoProfiler dataset, manuscript in preparation 2025</li>
                            <li><strong>TCR repertoire dynamics during treatment</strong> - Longitudinal analysis of clinical trial patients, in preparation 2025</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Software & Data Resources</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>ImmuneProfiler Suite</strong> - Comprehensive toolkit for immune profiling analysis</li>
                            <li><strong>TCR-Analytics</strong> - T-cell receptor repertoire analysis pipeline</li>
                            <li><strong>Multi-Modal Immune Integration Platform</strong> - Framework for integrating diverse immune profiling data</li>
                            <li><strong>Pancreatic Cancer Immune Atlas</strong> - Curated repository of immune profiling data</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Collaborations & Clinical Impact -->
            <div class="research-section">
                <h2>Collaborations & Clinical Impact</h2>
                <div class="project-card">
                    <h3>Interdisciplinary Research Network</h3>
                    <div class="project-description">
                        Our immune modeling research involves close collaboration with clinicians, immunologists, and 
                        computational biologists across multiple institutions. These partnerships ensure that our 
                        research addresses real clinical needs and can be rapidly translated to patient care.
                    </div>

                    <div class="project-details">
                        <h5>Key Collaborators</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Dr. Stephanie Dougan</strong> - Medical Oncology, immunotherapy clinical trials</li>
                            <li><strong>Dr. Brian Wolpin</strong> - Pancreatic cancer clinical research</li>
                            <li><strong>Dr. Jonathan Nowak</strong> - Pathology and biomarker development</li>
                            <li><strong>Hale Center Clinical Teams</strong> - Multi-institutional clinical trial network</li>
                        </ul>
                    </div>

                    <div class="clinical-application">
                        <h4>Direct Clinical Translation</h4>
                        <p>
                            Our research directly informs clinical trial design and patient treatment decisions at 
                            Dana-Farber and partner institutions. Biomarkers and predictive models developed through 
                            this work are being tested in prospective clinical trials, with the goal of improving 
                            immunotherapy response rates in pancreatic cancer patients.
                        </p>
                    </div>
                </div>
            </div>

            <!-- Future Directions -->
            <div class="research-section">
                <h2>Future Directions</h2>
                <div class="impact-highlight">
                    <h4>Next-Generation Immune Modeling</h4>
                    <p>
                        We are developing the next generation of immune modeling approaches that integrate spatial 
                        immune profiling with large language models. This will enable prediction of immunotherapy 
                        responses at unprecedented resolution and accuracy, potentially transforming how we select 
                        and monitor immunotherapy treatments in pancreatic cancer and other challenging cancer types.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>Computational Cancer Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script.js"></script>
</body>
</html>